Related Experiment Video
Updated: May 9, 2025

Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Serum uric acid levels as a causal factor in hypertension: Insights from Mendelian randomization analysis
Jiayue Xu1, Jiajing Zhao2, Jiaming Gu3
1Department of Traditional Chinese Medicine, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, Shanghai, China.
Insights
High serum uric acid (SUA) levels causally increase hypertension risk. This Mendelian randomization study confirms a one-way link, highlighting SUA management for blood pressure control.
Area of Science:
- Genetics
- Epidemiology
- Cardiovascular Disease
Background:
- Hyperuricemia and hypertension are common, often co-occurring chronic diseases.
- Observational studies suggest a link between serum uric acid (SUA) and hypertension, but causality is unclear due to confounding factors.
- This study uses Mendelian randomization (MR) to investigate the causal relationship between SUA levels and hypertension risk.
Purpose of the Study:
- To determine if elevated serum uric acid (SUA) levels causally influence the risk of developing hypertension.
- To differentiate the direction of causality between SUA and blood pressure using genetic variants.
- To provide robust evidence mitigating confounding and reverse causation inherent in observational studies.
Main Methods:
- Employed Mendelian randomization (MR) using single nucleotide polymorphisms (SNPs) as genetic instruments for serum uric acid (SUA) levels.
- Utilized a two-sample MR design with GWAS data from European populations.
- Assessed systolic and diastolic blood pressure as outcomes, with sensitivity analyses including weighted median and MR-Egger.
Main Results:
- Genetically predicted higher SUA levels showed a significant positive causal association with increased systolic blood pressure (SBP) and diastolic blood pressure (DBP).
- Reverse MR analysis indicated no significant causal effect of SBP or DBP on SUA levels, confirming a unidirectional relationship.
- Findings suggest a causal link where elevated SUA contributes to hypertension development.
Conclusions:
- This MR study provides strong evidence for a unidirectional causal relationship between higher SUA levels and an increased risk of hypertension.
- The findings underscore the clinical significance of managing SUA levels to reduce hypertension risk.
- Further research, including RCTs, is warranted to confirm these results and explore SUA-targeted interventions.
Background:
Hyperuricemia and hypertension are prevalent chronic diseases that often co-occur. While numerous observational studies suggest an association between serum uric acid (SUA) levels and hypertension, the causal nature of this relationship remains unresolved due to confounding and reverse causation. This study systematically investigates the causal association between SUA levels and hypertension risk using Mendelian randomization (MR) methodologies.
Methods:
We utilized single nucleotide polymorphisms (SNPs) identified in large-scale genome-wide association studies (GWAS) of European populations as genetic instruments for SUA levels. MR, a genetic epidemiology technique, uses genetic variations as proxies to mimic a randomized controlled trial and minimizing biases from confounding and reverse causation. Systolic and diastolic blood pressure (SBP and DBP) were the primary outcomes of interest. A two-sample MR analysis was conducted to assess the causal relationships, complemented by sensitivity analyses (weighted median, weighted mode, MR-Egger) to ensure result robustness. Findings are expressed as odds ratios (ORs) with 95% confidence intervals (Cis) per one standard deviation (SD) increase in SUA levels.
Results:
Our MR analysis identified a significant causal effect of SUA levels on hypertension risk. Specifically, genetically predicted SUA levels were positively associated with SBP (β = 0.136 [0.035-0.238], p < .05) and DBP (β = 0.108 [0.007-0.209], p < .05).Conversely, reverse MR analysis revealed no significant causal effect of SBP (b = 0.058 [ - 9.52E-05-0.116],p = .0504] or DBP (β = 0.016 [ - 0.028-0.059], p > .05] on SUA levels, confirming the unidirectional nature of this association.
Conclusion:
This study provides compelling evidence from MR supporting a unidirectional causal link between SUA levels and increased hypertension risk. Unlike prior observational studies, our genetic approach effectively mitigates confounding and reverse causation, offering novel insights into the etiology of hypertension. These findings highlight the clinical importance of managing SUA levels to mitigate hypertension risk. Further research, including randomized controlled trials, is needed to confirm these findings and explore potential therapeutic interventions targeting SUA.
More Related Videos
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Factors affecting Blood pressure
Physiological Factors:
Hormonal Regulation

